NGL Fine-Chem (NSE:NGLFINE) Change In Receivables: ₹0 Mil (TTM As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

NSE:NGLFINE NGL Fine-Chem Ltd NSE:NGLFINE
80 GF Score
Price ₹2,803.80
GF Value ₹3,044.25
Valuation Fairly Valued
! 4 Warning Signs
View Full Analysis

What is NGL Fine-Chem Change In Receivables?

NGL Fine-Chem NSE:NGLFINE -2.11% 80 Change In Receivables is ₹0 Mil as of Jun. 2026. GuruFocus rates NSE:NGLFINE with a GF Score™ of 80/100 and a GF Value™ of ₹3,044.25 (Fairly Valued). The stock has 4 warning signs investors should review.

NGL Fine-Chem's change in receivables for the quarter that ended in Jun. 2026 was ₹0 Mil. It means NGL Fine-Chem's Accounts Receivable stayed the same from Mar. 2026 to Jun. 2026 .

NGL Fine-Chem's change in receivables for the fiscal year that ended in Mar. 2026 was ₹-480 Mil. It means NGL Fine-Chem's Accounts Receivable increased by ₹480 Mil from Mar. 2025 to Mar. 2026 .

NGL Fine-Chem's Accounts Receivable for the quarter that ended in Jun. 2026 was ₹0 Mil.

Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed. NGL Fine-Chem's Days Sales Outstanding for the three months ended in Jun. 2026 was 0.00.

In Ben Graham's calculation of liquidation value, Apple Inc's Accounts Receivable are only considered to be worth 75% of book value. NGL Fine-Chem's liquidation value for the three months ended in Jun. 2026 was ₹0 Mil.

NGL Fine-Chem  (NSE:NGLFINE) Change In Receivables Explanation

1. Accounts Receivable are created when a customer has received a product but has not yet paid for that product. Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

NGL Fine-Chem's Days Sales Outstanding for the quarter that ended in Jun. 2026 is calculated as:

Days Sales Outstanding
=Accounts Receivable/Revenue*Days in Period
=0/1391.628*91
=0.00

2. In Ben Graham's calculation of liquidation value, NGL Fine-Chem's accounts receivable are only considered to be worth 75% of book value:

NGL Fine-Chem's liquidation value for the quarter that ended in Jun. 2026 is calculated as:

Liquidation Value
=Cash, Cash Equivalents, Marketable Securities-Total Liabilities+(0.75 * Accounts Receivable)+(0.5 * Total Inventories)
=0-0+0.75 * 0+0.5 * 0
=0

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

NGL Fine-Chem Change In Receivables Related Terms

NGL Fine-Chem Change In Receivables Historical Data

* Premium members only.

The historical data trend for NGL Fine-Chem's Change In Receivables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

NGL Fine-Chem Change In Receivables Chart

NGL Fine-Chem Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
Change In Receivables
Get a 7-Day Free Trial Premium Member Only Premium Member Only -264.19 -18.95 -237.47 64.13 -480.05

NGL Fine-Chem Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Change In Receivables Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00
NSE:NGLFINE
80GF Score
NGL Fine-Chem Ltd NSE:NGLFINE
Change In Receivables is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

NGL Fine-Chem Change In Receivables Calculation

Change In Accounts Receivable relative to the previous period. It is any increase or decrease in the cash a company is owed by its customers.

Change In Receivables for the trailing twelve months (TTM) ended in Jun. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹0 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Change In Receivables →
What does a Change In Receivables of ₹0 Mil mean?
NGL Fine-Chem (NSE:NGLFINE) has a Change In Receivables of ₹0 Mil as of Jun. 2026. Change in Receivables is the difference between current-period receivables and past-period receivables. View historical data for NGL Fine-Chem and its competitors.
Is NGL Fine-Chem's Change In Receivables too high?
NGL Fine-Chem's current Change In Receivables is ₹0 Mil. Overall, NGL Fine-Chem has a GF Score™ of 80/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does NGL Fine-Chem's Change In Receivables compare to LLY and JNJ?
NGL Fine-Chem's Change In Receivables of ₹0 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Change In Receivables for a Drug Manufacturers company?
A good Change In Receivables depends on the Drug Manufacturers industry context. However, Change In Receivables should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Change In Receivables mean?
A high Change In Receivables can signal that a stock is expensive relative to its fundamentals. Change in Receivables is the difference between current-period receivables and past-period receivables. View historical data for NGL Fine-Chem and its competitors. NGL Fine-Chem's current Change In Receivables is ₹0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is NGL Fine-Chem stock overvalued right now?
Based on GuruFocus' analysis, NGL Fine-Chem (NSE:NGLFINE) is currently considered Fairly Valued. The stock's GF Value™ is ₹3,044.25, compared to a current price of ₹2,803.80 — trading 7.9% below its estimated fair value. The current Change In Receivables is ₹0 Mil. NGL Fine-Chem's overall GF Score™ is 80/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Change In Receivables calculated?
Change In Receivables is calculated from a company's financial statements. For NGL Fine-Chem (NSE:NGLFINE), the current Change In Receivables is ₹0 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is NGL Fine-Chem (NSE:NGLFINE) Overvalued in 2026?

Based on GuruFocus' analysis, NGL Fine-Chem stock appears to be undervalued. The current stock price of ₹2,803.80 is trading 7.9% below its estimated GF Value™ of ₹3,044.25. GuruFocus considers NGL Fine-Chem to be Fairly Valued.

Key valuation signals for NSE:NGLFINE:

  • Change In Receivables: ₹0 Mil
  • GF Value™: ₹3,044.25 vs. price of ₹2,803.80 (7.9% below fair value)
  • GF Score™: 80/100 with 4 warning signs

No single metric tells the full story. See the NSE:NGLFINE stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

NGL Fine-Chem Business Description

Other Exchanges 524774:India
Address 301, E Square, Subhash Road, Vile Parle (East), Mumbai, MH, IND, 400057
NGL Fine-Chem Ltd is an Indian company engaged in the pharmaceutical business. It is a manufacturer of pharmaceuticals and intermediates for use in veterinary and human health, catering to various companies to custom-manufacture pharmaceuticals. The company's product portfolio comprises animal health APIs such as homidium chloride, nitroxynil, clorsulon, decoquinate, fenbendazole, etc.; human health APIs such as nitazoxanide and atovaquone; drug intermediates and specialty chemicals; and finished dosage forms such as diminazene aceturate granules and homidium chloride tablets. Geographically, the group generates maximum revenue from the Asia-Pacific region, and the rest from India, Europe, the USA, and the rest of the world.
80GF Score

Get the complete analysis for NSE:NGLFINE

Change In Receivables is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹2,803.80
Price
₹3,044.25
GF Value